Withdrawal of Inhaled Corticosteroids from COPD Patients Inhaling Long-Term Triple Therapy: The SUNSET Study

被引：0
|
作者：
Chapman, K. R. [1 ]
Hurst, J. [2 ]
Frent, S. [3 ]
Larbig, M. [4 ]
Fogel, R. [5 ]
Guerin, T. [6 ]
Banerji, D. [5 ]
Patalano, F. [4 ]
Goyal, P. [4 ]
Pfister, P. [4 ]
Kostikas, K. [4 ]
Wedzicha, J. A. [7 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Asthma & Airway Ctr, Toronto, ON, Canada
[2] UCL, UCL Resp, London, England
[3] Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania
[4] Novartis Pharma AG, Basel, Switzerland
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Novartis Ireland Ltd, Dublin, Ireland
[7] Imperial Coll London, Natl Heart & Lung Inst, Resp Clin Sci Sect, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1009
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
    Avdeev, Sergey
    Aisanov, Zaurbek
    Arkhipov, Vladimir
    Belevskiy, Andrey
    Leshchenko, Igor
    Ovcharenko, Svetlana
    Shmelev, Evgeny
    Miravitlles, Marc
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 1267 - 1280
  • [12] Pneumonia risk in COPD patients on long term inhaled corticosteroids - Data from the European COPD audit<%
    Saleh, Aarash
    Lopez-Campos, Jose
    Hartl, Sylvia
    Pozo-Rodriguez, Francisco
    Roberts, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [13] Inhaled corticosteroids withdrawal in COPD patients: why, when and how
    Patrucco, Filippo
    Solidoro, Paolo
    MINERVA PNEUMOLOGICA, 2020, 59 (01) : 1 - 3
  • [14] Review: Long-term use of inhaled corticosteroids increases fracture risk in COPD
    Seggev, Joram S.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (06)
  • [15] Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
    Cantoli, Marco
    Pauletti, Alessia
    Rossi, Maria Rita
    Spanevello, Antonio
    Casolari, Paolo
    Marcellini, Andrea
    Forini, Giacomo
    Gnesini, Giulia
    Marku, Brunilda
    Barnes, Neil
    Rizzi, Andrea
    Curradi, Giacomo
    Caramori, Gaetano
    Morelli, Paolo
    Papi, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (04)
  • [16] Long-term use of inhaled corticosteroids and the risk of type 2 diabetes in COPD
    Saeed, Mohamad Isam
    Eklof, Josefin
    Achir, Imane
    Sivapalan, Pradeesh
    Meteran, Howraman
    Lokke, Anders
    Sorensen, Tor-Biering
    Knop, Filip Krag
    Jensen, Jens-Ulrik Staehr
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [17] Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
    Miravitlles, Marc
    Auladell-Rispau, Ariadna
    Monteagudo, Monica
    Carlos Vazquez-Niebla, Juan
    Mohammed, Jibril
    Nunez, Alexa
    Urrutia, Gerard
    EUROPEAN RESPIRATORY REVIEW, 2021, 30 (160):
  • [18] Persistent blood eosinophilia and COPD exacerbation risk after ICS withdrawal from triple therapy in the SUNSET study
    Hurst, John R.
    Kostikas, Konstantinos
    Chapman, Kenneth R.
    Frent, Stefan-Marian
    Larbig, Michael
    Fogel, Robert
    Guerin, Tadhg
    Banerji, Donald
    Patalano, Francesco
    Goyal, Pankaj
    Pfister, Pascal
    Wedzicha, Jadwiga A.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [19] PERSISTENT BLOOD EOSINOPHILIA AND COPD EXACERBATION RISK AFTER ICS WITHDRAWAL FROM TRIPLE THERAPY IN THE SUNSET STUDY
    Kostikas, K.
    Hurst, J.
    Chapman, K.
    Frent, S.
    Larbig, M.
    Fogel, R.
    Guerin, T.
    Banerji, D.
    Patalano, F.
    Goyal, P.
    Pfister, P.
    Wedzicha, J.
    RESPIROLOGY, 2019, 24 : 51 - 51
  • [20] Long-term safety of inhaled corticosteroids in children
    S Pedersen
    Allergy, Asthma & Clinical Immunology, 6 (Suppl 1)
12345